MedTrace Logo

Intra-Nasal Mechanical Stimulation (INMEST) as a Treatment of Keratoconjunctivitis Sicca (Dry Eye Syndrome)

NCT03418259 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-12-13

No results posted yet for this study

Summary

The purpose of the study is to evaluate how treatment with Intra-Nasal Mechanical Stimulation (INMEST) in the nasal cavity in patients with Keratoconjunctivitis sicca can relieve these symtoms.

Conditions

  • Keratoconjunctivitis Sicca (KCS)

Interventions

DEVICE

KCS Medical Device

Patient treated 6 times with the Active KCS Medical Device during 2 weeks.

DEVICE

KCS Medical Device

Patient treated 6 times with the Inactive KCS Medical Device during 2 weeks.

Sponsors & Collaborators

Principal Investigators

  • Jan-Erik Juto, M.D., Ph.D. · Department of Clinical Science, Intervention and Technology (CLINTEC), H9, Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-12
Primary Completion
2022-07-01
Completion
2022-07-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03418259 on ClinicalTrials.gov